The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for those who have already taken two doses of Covishield or Covaxin.
Serum Institute of India CEO Adar Poonawalla on Sunday lauded India's fight against the Covid pandemic, saying the government and the healthcare workers contributed largely to tackling the pandemic in the country.
The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country, said Dr NK Arora, chairman of the Covid working group, National Technical Adviso
As per the complaint, Satish Deshpande, one of the directors at the SII had received a message on WhatsApp from a person posing as SII CEO Adar Poonawalla and was asked to send money into seven different accounts in September 2022. Believing the message was from Poonawala, Deshpande transfer
Mumbai (Maharashtra) [India], November 18 (ANI/PNN): One of India's emerging and community-first skincare brands Foxtale launched three of their latest entrants in an unique & immersive event - Wunderlabs, in the presence of new-age motion picture producer and style icon Rhea Kapoor. The
Estee Lauder has agreed to pay USD 2.8 billion to acquire Tom Ford's business. With a portfolio of brands that includes La Mer, Bobbi Brown, and Clinique, the Tom Ford deal also introduces clothes to Estee Lauder, a company which had previously been solely focused on the cosmetics industry.
Study revealed why metal copper are required by human cells to perform essential biological functions. The conclusion drawn from studies demonstrating higher copper levels in tumor cells and blood serum from cancer patients is that cancer cells require more copper than healthy cells.
Small amounts of the metal copper are required by human cells to perform essential biological functions. The conclusion drawn from studies demonstrating higher copper levels in tumor cells and blood serum from cancer patients is that cancer cells require more copper than healthy cells.
New Delhi [India], October 21 (ANI): The production of India's first indigenously developed quadrivalent Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer, by the Serum Institute of India will start in the first quarter of 2023 which got delayed due to C